UNDERSTANDING HOW EPITOPE BINDING INFLUENCES ANTIBODY DEPENDENT COMPLEMENT ENGAGEMENT FOR THERAPY OF B-CELL MALIGNANCIES

被引：0
|
作者：
Bondza, S. [1 ,2 ]
Buijs, J. [1 ,2 ]
Lux, A. [3 ]
机构：
[1] Uppsala Univ, Uppsala, Sweden
[2] Ridgeview Instruments, Uppsala, Sweden
[3] Friedrich Alexander Univ, Erlangen, Germany
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-ITOC9.2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
03.06
引用
收藏
页码：A1 / A1
页数：1
相关论文
共 50 条
  • [21] Antibody therapy of pediatric B-cell lymphoma
    Meyer-Wentrup, Friederike
    de Zwart, Verena
    Bierings, Marc
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [22] Monoclonal Antibody Therapy for B-Cell Lymphoma
    Antonio J. Grillo-López
    International Journal of Hematology, 2002, 76 : 385 - 393
  • [23] Monoclonal antibody therapy for B-cell lymphoma
    Grillo-López, AJ
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (05) : 385 - 393
  • [24] How does zanubrutinib fare in treatment of B-cell malignancies
    D'Sa, Shirley
    LANCET HAEMATOLOGY, 2023, 10 (01): : E5 - E6
  • [25] CAR T-cell cocktail therapy for B-cell malignancies
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2019, 20 (12): : E669 - E669
  • [26] Updates on CAR T-cell therapy in B-cell malignancies
    Jacoby, Elad
    Shahani, Shilpa A.
    Shah, Nirali N.
    IMMUNOLOGICAL REVIEWS, 2019, 290 (01) : 39 - 59
  • [27] Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
    Felberg, Anna
    Taszner, Michal
    Urban, Aleksandra
    Majeranowski, Alan
    Jaskula, Kinga
    Jurkiewicz, Aleksandra
    Stasilojc, Grzegorz
    Blom, Anna M.
    Zaucha, Jan M.
    Okroj, Marcin
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [28] Characterization of human IgG antimouse antibody in patients with B-cell malignancies
    DeNardo, GL
    Mirick, GR
    Kroger, LA
    Bradt, BM
    Lamborn, KR
    DeNardo, SJ
    CLINICAL CANCER RESEARCH, 2003, 9 (10) : 4013S - 4021S
  • [29] Bcl-2 antisense therapy in B-cell malignancies
    Chanan-Khan, A
    BLOOD REVIEWS, 2005, 19 (04) : 213 - 221
  • [30] Anti-CD74 antibody therapy with hLL1 (milatuzumab) for treatment of B-cell malignancies
    Martin, P.
    Furman, R.
    Elstrom, R.
    Ruan, J.
    Shore, T.
    Ely, S.
    Glynn, P.
    Niesvizky, R.
    Coleman, M.
    Sharkey, R.
    Vallabhajosula, S.
    Goldsmith, S.
    Goldenberg, D. M.
    Leonard, J. P.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 525 - 525
12345